First-to-market by the leader in Epigenetics research tools
- Useful for inhibitor screening or characterizing enzyme kinetics
- Includes optimal substrate selected from a panel of acetylated sites in p53 and histones
- Supplied with enough recombinant enzyme for 96 assays (1 x 96-well plate)
A FLUOR DE LYS® fluorescent assay system. The SIRT1 Fluorescent Activity Assay/Drug Discovery Kit is a complete assay system designed to measure the lysyl deacetylase activity of the recombinant human SIRT1 included in the kit. The kit is ideal for chemical library screening for candidate inhibitors or activators or kinetic assay of the enzyme under varying conditions. The FLUOR DE LYS® SIRT1 assay is based on the FLUOR DE LYS® SIRT1 Substrate and FLUOR DE LYS® Developer II combination. The assay procedure has two steps. First, the FLUOR DE LYS® SIRT1 Substrate, which contains a peptide comprising amino acids 379-382 of human p53 (Arg-His-Lys-Lys(Ac)). Deacetylation of the substrate sensitizes the substrate so that, in the second step, treatment with the FLUOR DE LYS®Developer II produces a fluorophore.
Yeast Sir2 (Silent information regulator 2) is the founding exemplar of the ’sirtuins’, an apparently ancient group of enzymes that occurs in eukaryotes, the archaea and eubacteria. In yeast and C. elegans, added copies of sirtuin genes extend lifespan and Sir2 is required for the lifespan extension conferred by caloric restriction in yeast. There are seven human sirtuins, which have been designated SIRT1-SIRT7. SIRT1, which is located in the nucleus, is the human sirtuin with the greatest homology to Sir2 and has been shown to exert a regulatory effect on p53 by deacetylation of lysine-382. Dr. Konrad Howitz at Enzo Life Sciences carried out a screen for modulators of SIRT1 activity which yielded a number of small molecule activators, all of which were plant polyphenols. Several of these Sirtuin Activating Compounds (STACs) extended yeast lifespan in a way that mimicked caloric restriction. Resveratrol, the most potent of these STACs activated SIRT1 in human cells and enhanced the survival rate of cells stressed by irradiation.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account

Figure: Reaction Scheme of the SIRT1 Fluorescent Activity Assay*. NAD+-dependent deacetylation of the substrate by recombinant human SIRT1 sensitizes it to Developer II, which then generates a fluorophore (symbol). The fluorophore is excited with 360 nm light and the emitted light (460 nm) is detected on a fluorometric plate reader. NAD+ is consumed in the reaction to produce nicotinamide (NAM) and O-acetyl-ADP-ribose.

Product Details
Alternative Name |
Sirtuin 1 fluorescent assay kit |
---|---|
Application |
Activity assay, Cell-based assays, Fluorescent detection, HTS |
Contents |
SIRT1 (Sirtuin 1, hSir2SIRT1) (human, recombinant) (Prod. No. BML-SE239) |
Technical Info / Product Notes |
Cited example: |
UniProt ID |
Q96EB6 |
Handling & Storage
Use/Stability |
Store all components except the microplates and instruction booklet at -80°C for the highest stability. The SIRT1 enzyme, (Prod. No. BML-SE239), must be handled with particular care in order to retain maximum enzymatic activity. Defrost it quickly in a RT water bath or by rubbing between fingers, then immediately store on an ice bath. The remaining unused enzyme should be refrozen quickly, by placing at -80°C. If possible, snap freeze in liquid nitrogen or a dry ice/ethanol bath. To minimize the number of freeze/thaw cycles, aliquot into separate tubes and store at -80°C. The 5x Developer II (Prod. No. BML-KI176) can be prone to precipitation if thawed too slowly. It is best to thaw this reagent in a room temperature water bath and, once thawed, transfer immediately onto ice. |
---|---|
Long Term Storage |
-80°C |
Shipping |
Dry Ice |
Regulatory Status |
RUO – Research Use Only |
---|
- Novel inhibitors of bromodomain and extra-terminal domain trigger cell death in breast cancer cell lines: M. Rahnasto-Rilla, et al.; Bioorg. Med. Chem. 112, 117884 (2024), Abstract
- Melatonin modulates the differentiation of neural stem cells exposed to manganese via SIRT1/β-catenin signaling: H. Zhou, et al.; Food Chem. Toxicol. 184, 114349 (2024), Abstract
- Adaptive epigenetic regulation of neuronal metabolism by a mitochondrial redox signal: Baeken, M. W., Kötzner, P., et al.; bioRxiv , (2023)
- Inhibition of phosphodiesterase 5A by tadalafil improves SIRT1 expression and activity in insulin-resistant podocytes: D. Rogacka, et al.; Cell. Signal. 105, 110622 (2023), Abstract
- eNAMPT actions through nucleus accumbens NAD+/SIRT1 link increased adiposity with sociability deficits programmed by peripuberty stress: L. Morató, et al.; Sci. Adv. 8, eabj9109 (2022), Abstract
- MHY2245, a Sirtuin Inhibitor, Induces Cell Cycle Arrest and Apoptosis in HCT116 Human Colorectal Cancer Cells: Y.J. Kang, et al.; Int. J. Mol. Sci. 23, 1590 (2022), Abstract
- Mitochondrial activity is the key to the protective effect of β-Lapachone, a NAD+ booster, in healthy cells against cisplatin cytotoxicity: S.Y. Lin, et al.; Phytomedicine 101, 154094 (2022), Abstract
- Augmentation of NAD+ by Dunnione Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice: S.H. Lee, et al.; J. Inflamm. Res. 15, 4623 (2022), Abstract
- Enhancement of cGMP-dependent pathway activity ameliorates hyperglycemia-induced decrease in SIRT1-AMPK activity in podocytes: Impact on glucose uptake and podocyte function: D. Rogacka, et al.; Biochim. Biophys. Acta Mol. Cell Res. 1869, 119362 (2022), Abstract
- Tetrahydrocurcumin protects against sepsis-induced acute kidney injury via the SIRT1 pathway: Li, L., Liu, X., et al.; Ren. Fail. 43, 1028 (2021), Abstract
- Perfluorooctane sulfonate continual exposure impairs glucose-stimulated insulin secretion via SIRT1-induced upregulation of UCP2 expression: X. Duan, et al.; Environ. Pollut. 278, 116840 (2021), Abstract
- Quercetin 3,5,7,3′,4′-pentamethyl ether from Kaempferia parviflora directly and effectively activates human SIRT1: M. Zhang, et al.; Commun. Biol. 4, 209 (2021), Abstract — Full Text
- Involvement of nitric oxide synthase/nitric oxide pathway in the regulation of SIRT1-AMPK crosstalk in podocytes: Impact on glucose uptake: D. Rogacka, et al.; Arch. Biochem. Biophys. 709, 108985 (2021), Abstract
- Structure-Guided Design of a Small-Molecule Activator of Sirtuin-3 that Modulates Autophagy in Triple Negative Breast Cancer: J. Zhang, et al.; J. Med. Chem. 64, 114192 (2021), Abstract
- Silymarin ameliorates the disordered glucose metabolism of mice with diet-induced obesity by activating the hepatic SIRT1 pathway: B. Feng, et al.; Cell. Signal. 84, 110023 (2021), Abstract
- SIRT1-Dependent Upregulation of BDNF in Human MicrogliaChallenged with Aβ: An Early but Transient Response Rescuedby Melatonin: G.I. Caruso, et al.; Biomedicines 9, 466 (2021), Abstract
- Unexpected beta-amyloid production by middle doses of resveratrol through stabilization of APP protein and AMPK-mediated inhibition of trypsin-like proteasome activity i: B.G. Jang, et al.; Food Chem. Toxicol. 152, 112185 (2021), Abstract
- Analysis of Sirtuin 1 and Sirtuin 3 at Enzyme and Protein Levels in Human Breast Milk during the Neonatal Period: K. Hase, et al.; Metabolites 11, 348 (2021), Abstract — Full Text
- Shrimp SIRT1 activates of the WSSV IE1 promoter independently of the NF-κB binding site: Z.N. Kao, et al.; Fish Shellfish Immunol. 106, 910 (2020), Application(s): Sirt1 activity in shrimp hempcyte samples, Abstract
- Synergistic Effect of Dietary Betaines on SIRT1-Mediated Apoptosis in Human Oral Squamous Cell Carcinoma Cal 27: D’Onofrio, N., Mele, L., et al.; Cancers (Basel) 12, (2020), Abstract
- Osirisynes G-I, New Long-Chain Highly Oxygenated Polyacetylenes from the Mayotte Marine Sponge Haliclona sp.: P.E. Campos, et al.; Mar. Drugs 18, 350 (2020), Abstract
- Microorganisms Associated with the Marine Sponge Scopalina hapalia: A Reservoir of Bioactive Molecules to Slow Down the Aging Process: C.S. Hassane, et al.; Microorganisms 20, 1262 (2020), Application(s): Sirtuin activation by microbial crude extracts., Abstract
- Isoparvifuran isolated from Dalbergia odorifera attenuates H2O2-induced senescence of BJ cells through SIRT1 activation and AKT/mTOR pathway inhibition: Z. Yin, et al.; Biochem. Biophys. Res. Commun. 533, 925 (2020), Abstract
- Ellagic acid protects against diabetic cardiomyopathy in rats by stimulating cardiac silent information regulator 1 signaling: Altamimi, J. Z., Alfaris, N. A., et al.; J. Physiol. Pharmacol. 71, (2020), Abstract
- Novel SIRT Inhibitor, MHY2256, Induces Cell Cycle Arrest, Apoptosis, and Autophagic Cell Death in HCT116 Human Colorectal Cancer Cells: M.J. Kim, et al.; Biomol. Ther. (Seoul) 28, 561 (2020), Abstract — Full Text
- Antiproliferative activity of (R)-4′-methylklavuzon on hepatocellular carcinoma cells and EpCAM+/CD133+ cancer stem cells via SIRT1 and Exportin-1 (CRM1) inhibition: M. Delman, et al.; Eur. J. Med. Chem. 180, 224 (2019), Abstract
- Molecular and Cellular Characterization of SIRT1 Allosteric Activators: M.B. Schultz, et al.; Methods Mol. Biol. 1983, 133 (2019), Abstract
- Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors: G. Eren, et al.; J. Mol. Graph. Model. 10, 1313 (2019), Abstract
- Regulation of sirtuin expression in autoimmune neuroinflammation: Induction of SIRT1 in oligodendrocyte progenitor cells: T. Prozorovski, et al.; Neurosci. Lett. 704, 116 (2019), Abstract
- A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo: L. Santos, et al.; Sci. Rep. 9, 14381 (2019), Abstract — Full Text
- Decrease in membrane phospholipids unsaturation correlates with myocardial diastolic dysfunction: T. Yamamoto, et al.; PLoS One 13, e30533011 (2018), Abstract
- A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline: Tarragó, M. G., Chini, C. C. S., et al.; Cell Metab. 27, 1081 (2018), Abstract
- Two Novel Proline-Containing Catechin Glucoside from Water-Soluble Extract of Codonopsis pilosula: F.Y. Qin, et al.; Molecules 23, E180 (2018), Application(s):SIRT1 Inhibition, Abstract — Full Text
- Resveratrol ameliorates prenatal progestin exposure-induced autism-like behavior through ERβ activation: W. Xie, et al.; Mol. Autism 9, 43 (2018), Abstract — Full Text
- SIRT1 activator E1231 protects from experimental atherosclerosis and lowers plasma cholesterol and triglycerides by enhancing ABCA1 expression: T. Feng, et al.; Atherosclerosis 274, 172 (2018), Abstract
- Honokiol Ameliorates Myocardial Ischemia/Reperfusion Injury in Type 1 Diabetic Rats by Reducing Oxidative Stress and Apoptosis through Activating the SIRT1-Nrf2 Signaling Pathway: B. Zhang, et al.; Oxid. Med. Cell. Longev. 2018, 3159801 (2018), Abstract — Full Text
- Erythropoietin alleviates hepatic steatosis by activating SIRT1-mediated autophagy: T. Hong, et al.; Biochim. Biophys. Acta Mol. Cell. Biol. Lipids 1863, 595 (2018), Abstract
- Phosphorylated SIRT1 associates with replication origins to prevent excess replication initiation and preserve genomic stability: K. Utani, et al.; Nucleic Acids Res. 45, 7807 (2017), Abstract — Full Text
- SIRT1 may play a crucial role in overload-induced hypertrophy of skeletal muscle: E. Koltai, et al.; J. Physiol. 595, 3361 (2017), Abstract — Full Text
- Design, synthesis of allosteric peptide activator for human SIRT1 and its biological evaluation in cellular model of Alzheimer’s disease: R. Kumar, et al.; Eur. J. Med. Chem. 127, 909 (2017), Abstract
- Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1: D. Shao, et al.; Antioxid. Redox Signal. 27, 313 (2017), Abstract — Full Text
- Obesity-Linked Phosphorylation of SIRT1 by Casein Kinase 2 Inhibits Its Nuclear Localization and Promotes Fatty Liver: S.E. Choi, et al.; Mol. Cell. Biol. 37, e00006 (2017), Abstract — Full Text
- Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients: R. Li, et al.; J. Neuroimmunol. 313, 56 (2017), Abstract
- Scopolin ameliorates high-fat diet induced hepatic steatosis in mice: potential involvement of SIRT1-mediated signaling cascades in the liver: A. Yoo, et al.; Sci. Rep. 7, 2251 (2017), Abstract — Full Text
- A novel SIRT1 inhibitor, 4bb induces apoptosis in HCT116 human colon carcinoma cells partially by activating p53: A. Ghosh, et al.; Biochem. Biophys. Res. Commun. 488, 562 (2017), Abstract
- Aquatide Activation of SIRT1 Reduces Cellular Senescence through a SIRT1-FOXO1-Autophagy Axis: C.J. Lim, et al.; Biomol. Ther. 25, 511 (2017), Abstract — Full Text
- How much successful are the medicinal chemists in modulation of SIRT1: A critical review: A. Kumar, et al.; Eur. J. Med. Chem. 119, 45 (2016), Abstract
- Nuclear Perilipin 5 integrates lipid droplet lipolysis with PGC-1α/SIRT1-dependent transcriptional regulation of mitochondrial function: Gallardo-Montejano, V. I., Saxena, G., et al.; Nat. Commun. 7, 12723 (2016), Abstract
- Protective Effects of Hydrogen Sulfide in the Ageing Kidney: C.L. Hou, et al.; Oxid. Med. Cell. Longevity 2016, 7570489 (2016), Abstract — Full Text
- Dunnione ameliorates cisplatin ototoxicity through modulation of NAD+ metabolism: H.J. Kim, et al.; Hear Res. 333, 235 (2016), Application(s): SIRT1 activity Assay, Abstract
- SIRT3 Deacetylates Ceramide Synthases: Implications for Mitochondrial Dysfunction and Brain Injury: S.A. Novgorodov, et al.; J. Biol. Chem. 291, 1957 (2016), Application(s): Deacetylation assay with mouse brain cells, Abstract — Full Text
- The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway: J. Zhang, et al.; Biochem. Pharmacol. 101, 100 (2016), Application(s): SIRT1 deacetylase activity, Abstract
- Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes: D.A. Duarte, et al.; PLoS One 11, e0147978 (2016), Application(s): Measured SIRT1 activity, Abstract — Full Text
- SIRT1-AMPK crosstalk is involved in high glucose-dependent impairment of insulin responsiveness in primary rat podocytes: D. Rogacka, et al.; Exp. Cell. Res. 349, 328 (2016), Abstract
- Caspase-2 deficiency accelerates chemically induced liver cancer in mice: S. Shalini, et al.; Cell Death Differ. 23, 1727 (2016), Application(s): Measurement of liver metabolites and Sirt1 and Sirt3 activities, Abstract
- SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway: C.C. Chini et al.; Clin. Cancer Res. 22, 2496 (2016), Abstract
- Hormetic shifting of redox environment by pro-oxidative resveratrol protects cells against stress: A. Plauth, et al.; Free Radic. Biol. Med. 99, 608 (2016), Abstract
- Dunnione ameliorates cisplatin-induced small intestinal damage by modulating NAD+ metabolism: A. Pandit, et al.; Biochem. Biophys. Res. Commun. 467, 697 (2015), Application(s): Determination of SIRT1 activity, Abstract
- SIRT1 inhibition in pancreatic cancer models: Contrasting effects in vitro and in vivo: C. E. Oon, et al.; Eur. J. Pharmacol. 757, 59 (2015), Application(s): Fluorescence microscopy , Abstract
- Virtual screening approach of sirtuin inhibitors results in two new scaffolds: P. Kokkonen, et al.; Eur. J. Pharm. Sci. 76, 27 (2015), Application(s): Assay, Abstract
- Leucine Amplifies the Effects of Metformin on Insulin Sensitivity and Glycemic Control in Diet-Induced Obese Mice: L. Fu, et al.; Metabolism 64, 845 (2015), Application(s): Assay, Abstract
- SIRT5 regulation of ammonia-induced autophagy and mitophagy: L. Polletta, et al.; Autophagy 11, 253 (2015), Abstract — Full Text
- Curcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1: A. Hu, et al.; Sci. Rep. 5, Article number 13429 (2015), Application(s): Deacetylase assay in HNSCC cell lines, Abstract — Full Text
- BET Inhibition Upregulates SIRT1 and Alleviates Inflammatory Responses: T. Kokkola, et al.; Chembiochem 16, 1997 (2015), Abstract — Full Text
- Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors: E. Therrien, et al.; Bioorg. Med. Chem. Lett. 25, 2514 (2015), Abstract
- Resveratrol delays Wallerian degeneration in a NAD(+) and DBC1 dependent manner: A. Calliari, et al.; Exp. Neurol. 251, 91 (2014), Abstract
- Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways: C. Valle, et al.; Cell Death Dis. 5, e1296 (2014), Abstract — Full Text
- Leucine Modulates Mitochondrial Biogenesis and SIRT1-AMPK Signaling in C2C12 Myotubes: Liang, C., Curry, B. J., et al.; J. Nutr. Metab. 2014, 239750 (2014), Abstract
- Coumestrol induces mitochondrial biogenesis by activating Sirt1 in cultured skeletal muscle cells: D.B. Seo, et al.; J. Agric. Food Chem. 62, 4298 (2014), Abstract
- A redox-resistant sirtuin-1 mutant protects against hepatic metabolic and oxidant stress: D. Shao, et al.; J. Biol. Chem. 289, 7293 (2014), Abstract
- Mechanism of inhibition of the human sirtuin enzyme SIRT3 by nicotinamide: computational and experimental studies: Guan, X., Lin, P., et al.; PLoS One 9, e107729 (2014), Abstract
- Sirtuin 1 activity in peripheral blood mononuclear cells of patients with osteoporosis: M. Godfrin-Valnet, et al.; Med. Sci. Monit. Basic Res. 20, 142 (2014), Abstract — Full Text
- Modulation of the AMPK/Sirt1 axis during neuronal infection by herpes simplex virus type 1: C. Martin, et al.; J. Alzheimers Dis. 42, 301 (2014), Abstract
- Synergistic Effects of Polyphenols and Methylxanthines with Leucine on AMPK/Sirtuin-Mediated Metabolism in Muscle Cells and Adipocytes: A. Bruckbauer & M.B. Zemel; PLoS One 9, e89166 (2014), Abstract — Full Text
- Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors: T. Suzuki, et al.; ChemMedChem. 9, 657 (2014), Abstract
- Modulation of p53 C-terminal acetylation by mdm2, p14ARF, and cytoplasmic SirT2: I.M. van Leeuwen, et al.; Mol. Cancer Ther. 12, 471 (2013), Abstract — Full Text
- Cytotoxicity and cell death mechanisms induced by a novel bisnaphthalimidopropyl derivative against the NCI-H460 non-small lung cancer cell line: R.T. Lima, et al.; Anticancer Agents Med. Chem. 13, 414 (2013), Abstract
- Tenovin-D3, a novel small-molecule inhibitor of sirtuin SirT2, increases p21 (CDKN1A) expression in a p53-independent manner: A.R. McCarthy, et al.; Mol. Cancer Ther. 12, 352 (2013), Abstract — Full Text
- Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis: G. Li, et al.; Cancer Prev. Res. (Phila) 6, 27 (2013), Abstract — Full Text
- Rejuvenating sirtuins: the rise of a new family of cancer drug targets: S. Bruzzone, et al.; Curr. Pharm. Des. 19, 614 (2013), Abstract — Full Text
- Effects of Resveratrol on the Recovery of Muscle Mass Following Disuse in the Plantaris Muscle of Aged Rats: B. Bennett, et al.; PLoS One 8, e83518 (2013), Abstract — Full Text
- Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo: J.C. Escola-Gil, et al.; Transl. Res. 161, 110 (2013), Abstract
- Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity: A. Bruckbauer & M.B. Zemel; Diabetes Metab. Syndr. Obes. 6, 93 (2013), Abstract — Full Text
- Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice: A. Bruckbauer, et al.; Nutr. Metab. (Lond.) 9, 77 (2012), Abstract — Full Text
- Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase: V. Nin, et al.; J. Biol. Chem. 287, 23489 (2012), Application(s): SIRT1 activity measurement in cells, Abstract — Full Text
- A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates: M.A. Suter, et al.; FASEB J. 26, 5106 (2012), Application(s): HDAC activity in fetal macaque liver or Cos-1 cell extracts, Abstract — Full Text
- SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity: M. Pan, et al.; J. Biol. Chem. 287, 2468 (2012), Abstract — Full Text
- Effects of dairy consumption on SIRT1 and mitochondrial biogenesis in adipocytes and muscle cells: A. Bruckbauer & M.B. Zemel; Nutr. Metab. (Lond.) 8, 91 (2011), Abstract — Full Text
- SIRT1 Activates MAO-A in the Brain to Mediate Anxiety and Exploratory Drive: S. Libert, et al.; Cell 147, 1459 (2011), Abstract — Full Text
- Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation: A.A. Kendrick, et al.; Biochem. J. 433, 505 (2011), Application(s): SIRT1 activity in mouse liver cells, Abstract — Full Text
- Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila: C. Burnett, et al.; Nature 477, 482 (2011), Application(s): Drosophila’s Sir2 deacetylation assay, Abstract — Full Text
- SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53: D.H. Kim, et al.; Am. J. Physiol. Renal Physiol. 301, F427 (2011), Application(s): Activity of immunoprecipitated SIRT1, Abstract — Full Text
- SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2: B. Peck, et al.; Mol. Cancer Ther. 9, 844 (2010), Abstract — Full Text
- SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183: J.L. Huber, et al.; Future Med. Chem. 2, 1751 (2010), Abstract
- Identification and characterization of novel sirtuin inhibitor scaffolds: B.D. Sanders, et al.; Bioorg. Med. Chem. 17, 7031 (2009), Application(s): HTS application. Use of 384-well plates with this kit, Abstract — Full Text
Related Products

Alternative Name | 3,4,3′,5′-Tetrahydroxy-trans-stilbene |
---|---|
CAS | 10083-24-6 |
Couple Type | Activator, Inhibitor |
Purity | ≥98% (HPLC (UV)) |

Alternative Name | Sirtuin 1 |
---|---|
Source | Produced in E. coli. Recombinant SIRT1 from human cDNA containing an N-terminal His-tag. |

Alternative Name | trans-3,4′,5-Trihydroxystilbene |
---|---|
CAS | 501-36-0 |
Couple Type | Activator, Inhibitor, Ligand |
Purity | ≥98% (HPLC) |
Datasheet, Manuals, SDS & CofA
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form